Terms: = Bone cancer AND MLLT3, AF9, 4300, ENSG00000171843, P42568, YEATS3, AF-9 AND Treatment
21 results:
1. Distinct and targetable role of calcium-sensing receptor in leukaemia.
Pereira RS; Kumar R; Cais A; Paulini L; Kahler A; Bravo J; Minciacchi VR; Krack T; Kowarz E; Zanetti C; Godavarthy PS; Hoeller F; Llavona P; Stark T; Tascher G; Nowak D; Meduri E; Huntly BJP; Münch C; Pampaloni F; Marschalek R; Krause DS
Nat Commun; 2023 Oct; 14(1):6242. PubMed ID: 37802982
[TBL] [Abstract] [Full Text] [Related]
2. A multicenter retrospective analysis of clinical outcomes of intracranial chondrosarcoma in 26 patients.
Liu H; Li Z; Xue Y; Zhao T; Wu Y
Sci Rep; 2023 Sep; 13(1):14647. PubMed ID: 37669996
[TBL] [Abstract] [Full Text] [Related]
3. Poor treatment responses were related to poor outcomes in pediatric B cell acute lymphoblastic leukemia with KMT2A rearrangements.
Wen J; Zhou M; Shen Y; Long Y; Guo Y; Song L; Xiao J
BMC Cancer; 2022 Aug; 22(1):859. PubMed ID: 35933338
[TBL] [Abstract] [Full Text] [Related]
4. NADPH metabolism determines the leukemogenic capacity and drug resistance of AML cells.
Chen C; Lai X; Zhang Y; Xie L; Yu Z; Dan S; Jiang Y; Chen W; Liu L; Yang Y; Huang D; Zhao Y; Zheng J
Cell Rep; 2022 Apr; 39(1):110607. PubMed ID: 35385727
[TBL] [Abstract] [Full Text] [Related]
5. The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.
Khateb A; Deshpande A; Feng Y; Finlay D; Lee JS; Lazar I; Fabre B; Li Y; Fujita Y; Zhang T; Yin J; Pass I; Livneh I; Jeremias I; Burian C; Mason JR; Almog R; Horesh N; Ofran Y; Brown K; Vuori K; Jackson M; Ruppin E; Deshpande AJ; Ronai ZA
Nat Commun; 2021 Sep; 12(1):5397. PubMed ID: 34518534
[TBL] [Abstract] [Full Text] [Related]
6. Therapy-induced Deletion in 11q23 Leading to Fusion of
Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897
[TBL] [Abstract] [Full Text] [Related]
7. SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation.
Ropa J; Saha N; Hu H; Peterson LF; Talpaz M; Muntean AG
Haematologica; 2020 Sep; 105(9):2273-2285. PubMed ID: 33054052
[TBL] [Abstract] [Full Text] [Related]
8. EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase.
Saito Y; Sawa D; Kinoshita M; Yamada A; Kamimura S; Suekane A; Ogoh H; Matsuo H; Adachi S; Taga T; Tomizawa D; Osato M; Soga T; Morishita K; Moritake H
Haematologica; 2020 Aug; 105(8):2118-2129. PubMed ID: 31649131
[TBL] [Abstract] [Full Text] [Related]
9. Critical role of ASCT2-mediated amino acid metabolism in promoting leukaemia development and progression.
Ni F; Yu WM; Li Z; Graham DK; Jin L; Kang S; Rossi MR; Li S; Broxmeyer HE; Qu CK
Nat Metab; 2019 Mar; 1(3):390-403. PubMed ID: 31535081
[TBL] [Abstract] [Full Text] [Related]
10. Genetic alteration patterns and clinical outcomes of elderly and secondary acute myeloid leukemia.
Wang SY; Cheng WY; Mao YF; Zhu YM; Liu FJ; Ma TT; Shen Y
Hematol Oncol; 2019 Oct; 37(4):456-463. PubMed ID: 31348835
[TBL] [Abstract] [Full Text] [Related]
11. Opposing effects of acute versus chronic inhibition of p53 on decitabine's efficacy in myeloid neoplasms.
Tamura M; Yonezawa T; Liu X; Asada S; Hayashi Y; Fukuyama T; Tanaka Y; Kitamura T; Goyama S
Sci Rep; 2019 Jun; 9(1):8171. PubMed ID: 31160638
[TBL] [Abstract] [Full Text] [Related]
12. The transcriptional regulator FUBP1 influences disease outcome in murine and human myeloid leukemia.
Hoang VT; Verma D; Godavarthy PS; Llavona P; Steiner M; Gerlach K; Michels BE; Bohnenberger H; Wachter A; Oellerich T; Müller-Kuller U; Weissenberger E; Voutsinas JM; Oehler VG; Farin HF; Zörnig M; Krause DS
Leukemia; 2019 Jul; 33(7):1700-1712. PubMed ID: 30635626
[TBL] [Abstract] [Full Text] [Related]
13. ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia.
Wang Y; Skibbe JR; Hu C; Dong L; Ferchen K; Su R; Li C; Huang H; Weng H; Huang H; Qin X; Jin J; Chen J; Jiang X
Sci Rep; 2017 May; 7(1):1853. PubMed ID: 28500307
[TBL] [Abstract] [Full Text] [Related]
14. Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
Ballinger ML; Goode DL; Ray-Coquard I; James PA; Mitchell G; Niedermayr E; Puri A; Schiffman JD; Dite GS; Cipponi A; Maki RG; Brohl AS; Myklebost O; Stratford EW; Lorenz S; Ahn SM; Ahn JH; Kim JE; Shanley S; Beshay V; Randall RL; Judson I; Seddon B; Campbell IG; Young MA; Sarin R; Blay JY; O'Donoghue SI; Thomas DM;
Lancet Oncol; 2016 Sep; 17(9):1261-71. PubMed ID: 27498913
[TBL] [Abstract] [Full Text] [Related]
15. Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated Cytolysis.
Hasegawa K; Tanaka S; Fujiki F; Morimoto S; Nakano K; Kinoshita H; Okumura A; Fujioka Y; Urakawa R; Nakajima H; Tatsumi N; Nakata J; Takashima S; Nishida S; Tsuboi A; Oka Y; Oji Y; Miyoshi E; Hirata T; Kumanogoh A; Sugiyama H; Hosen N
PLoS One; 2016; 11(3):e0152326. PubMed ID: 27011118
[TBL] [Abstract] [Full Text] [Related]
16. MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.
Roychoudhury J; Clark JP; Gracia-Maldonado G; Unnisa Z; Wunderlich M; Link KA; Dasgupta N; Aronow B; Huang G; Mulloy JC; Kumar AR
Blood; 2015 Apr; 125(16):2544-52. PubMed ID: 25740828
[TBL] [Abstract] [Full Text] [Related]
17. Differential regulation of myeloid leukemias by the bone marrow microenvironment.
Krause DS; Fulzele K; Catic A; Sun CC; Dombkowski D; Hurley MP; Lezeau S; Attar E; Wu JY; Lin HY; Divieti-Pajevic P; Hasserjian RP; Schipani E; Van Etten RA; Scadden DT
Nat Med; 2013 Nov; 19(11):1513-7. PubMed ID: 24162813
[TBL] [Abstract] [Full Text] [Related]
18. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-af9 oncoprotein.
Jenkins CE; Shevchuk OO; Giambra V; Lam SH; Carboni JM; Gottardis MM; Holzenberger M; Pollak M; Humphries RK; Weng AP
Exp Hematol; 2012 Sep; 40(9):715-723.e6. PubMed ID: 22613471
[TBL] [Abstract] [Full Text] [Related]
19. Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemia.
Metzler M; Strissel PL; Strick R; Niemeyer C; Roettgers S; Borkhardt A; Harbott J; Ludwig WD; Stanulla M; Schrappe M; Reinhardt D; Creutzig U; Beck JD; Rascher W; Repp R; Langer T
Genes Chromosomes Cancer; 2004 Nov; 41(3):291-6. PubMed ID: 15334554
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
Langer T; Metzler M; Reinhardt D; Viehmann S; Borkhardt A; Reichel M; Stanulla M; Schrappe M; Creutzig U; Ritter J; Leis T; Jacobs U; Harbott J; Beck JD; Rascher W; Repp R
Genes Chromosomes Cancer; 2003 Apr; 36(4):393-401. PubMed ID: 12619163
[TBL] [Abstract] [Full Text] [Related]
[Next]
